These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 35963740)

  • 21. Nitric oxide for respiratory failure in infants born at or near term.
    Finer NN; Barrington KJ
    Cochrane Database Syst Rev; 2001; (2):CD000399. PubMed ID: 11405963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension.
    Cornfield DN; Maynard RC; deRegnier RA; Guiang SF; Barbato JE; Milla CE
    Pediatrics; 1999 Nov; 104(5 Pt 1):1089-94. PubMed ID: 10545552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn.
    Wessel DL; Adatia I; Van Marter LJ; Thompson JE; Kane JW; Stark AR; Kourembanas S
    Pediatrics; 1997 Nov; 100(5):E7. PubMed ID: 9347001
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pulmonary vasodilator strategies in neonates with acute hypoxemic respiratory failure and pulmonary hypertension.
    Cookson MW; Abman SH; Kinsella JP; Mandell EW
    Semin Fetal Neonatal Med; 2022 Aug; 27(4):101367. PubMed ID: 35688685
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent pulmonary hypertension of the newborn.
    Teng RJ; Wu TJ
    J Formos Med Assoc; 2013 Apr; 112(4):177-84. PubMed ID: 23537863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The management of neonatal pulmonary hypertension.
    Dhillon R
    Arch Dis Child Fetal Neonatal Ed; 2012 May; 97(3):F223-8. PubMed ID: 21278430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Airway function in infants treated with inhaled nitric oxide for persistent pulmonary hypertension.
    Hoskote AU; Castle RA; Hoo AF; Lum S; Ranganathan SC; Mok QQ; Stocks J
    Pediatr Pulmonol; 2008 Mar; 43(3):224-35. PubMed ID: 18203182
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recent advances in the pathogenesis and treatment of persistent pulmonary hypertension of the newborn.
    Abman SH
    Neonatology; 2007; 91(4):283-90. PubMed ID: 17575471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Persistent pulmonary hypertension of the newborn: pathogenesis, etiology, and management.
    Ostrea EM; Villanueva-Uy ET; Natarajan G; Uy HG
    Paediatr Drugs; 2006; 8(3):179-88. PubMed ID: 16774297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in the diagnosis and management of persistent pulmonary hypertension of the newborn.
    Konduri GG; Kim UO
    Pediatr Clin North Am; 2009 Jun; 56(3):579-600, Table of Contents. PubMed ID: 19501693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nitric oxide for respiratory failure in infants born at or near term.
    Barrington KJ; Finer N; Pennaforte T; Altit G
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD000399. PubMed ID: 28056166
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal thyrotoxicosis and persistent pulmonary hypertension necessitating extracorporeal life support.
    Oden J; Cheifetz IM
    Pediatrics; 2005 Jan; 115(1):e105-8. PubMed ID: 15629961
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of nonsteroidal antiinflammatory drugs in meconium and its relation to persistent pulmonary hypertension of the newborn.
    Alano MA; Ngougmna E; Ostrea EM; Konduri GG
    Pediatrics; 2001 Mar; 107(3):519-23. PubMed ID: 11230592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of a novel nitric oxide generator for the treatment of neonatal pulmonary hypertension: Experimental and clinical studies.
    Blasina F; Vaamonde L; Silvera F; Solla G; Abin-Carriquiry JA; Gutiérrez C; Beltramo P; Garcia-Gabay I; Martell M
    Pulm Pharmacol Ther; 2019 Feb; 54():68-76. PubMed ID: 30529287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Persistent pulmonary hypertension of the newborn.
    Mandell E; Kinsella JP; Abman SH
    Pediatr Pulmonol; 2021 Mar; 56(3):661-669. PubMed ID: 32930508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated immunoreactive endothelin-1 levels in newborn infants with persistent pulmonary hypertension.
    Rosenberg AA; Kennaugh J; Koppenhafer SL; Loomis M; Chatfield BA; Abman SH
    J Pediatr; 1993 Jul; 123(1):109-14. PubMed ID: 8320603
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhaled nitric oxide enhances oxygenation but not survival in infants with alveolar capillary dysplasia.
    Steinhorn RH; Cox PN; Fineman JR; Finer NN; Rosenberg EM; Silver MM; Tyebkhan J; Zwass MS; Morin FC
    J Pediatr; 1997 Mar; 130(3):417-22. PubMed ID: 9063417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical pathophysiology of persistent pulmonary hypertension of the newborn and the role of inhaled nitric oxide therapy.
    Kinsella JP; Abman SH
    J Perinatol; 1996; 16(2 Pt 2 Su):S24-7. PubMed ID: 8732545
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenesis and treatment of neonatal and postnatal pulmonary hypertension.
    Abman SH
    Curr Opin Pediatr; 1994 Jun; 6(3):239-47. PubMed ID: 8061732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nitric oxide in neonatal hypoxemic respiratory failure.
    Muraca MC; Negro S; Sun B; Buonocore G
    J Matern Fetal Neonatal Med; 2012 Apr; 25 Suppl 1():47-50. PubMed ID: 22372677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.